Test your knowledge of newly diagnosed multiple myeloma

What is the preferred regimen to consider for a newly diagnosed myeloma patient with standard risk features?
Lenalidomide/dex (Rd)
Lenalidomide/bortezomib/dex (RVd)
Daratumumab/ Lenalidomide/bortezomib/dex (Dara/RVd)
Bortezomib/daratumumab/dex
A bone agent is only needed if there is detected bone disease.
True
False
Choose the best answer below regarding MRD.
There is no variability in MRD testing
MRD is one of the most informative parameters to discriminate responses to treatment and prognosis
MRD is not considered in clinical trials
There is consensus among myeloma specialist on the preferred use of MRD
{"name":"Test your knowledge of newly diagnosed multiple myeloma", "url":"https://www.quiz-maker.com/Q61GY1JC3","txt":"What is the preferred regimen to consider for a newly diagnosed myeloma patient with standard risk features?, A bone agent is only needed if there is detected bone disease., Choose the best answer below regarding MRD.","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys